Under the joint research collaboration agreement, which covers activities from candidate drug generation up until IND-enabling studies, each company will...
Read more
Novavax Plan Outlines Expansion of Gaithersburg Corporate Campus Company says it could add 400 jobs within four years The biotechnology...
CARB-X is funding Novel Microdevices to develop a rapid and portable diagnostic for sexually transmitted diseases including antibiotic-resistant infections New portable battery-powered...
Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the...
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the initiation of crossover...
